CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Shares withheld for taxes President and CEO gave up 30,610 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 1,108 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 881 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 2,231 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Grant or award Chief Financial Officer acquired 117,770 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Scientific Officer gave up 303 shares (to pay taxes)
- 4 Grant or award Chief Operating Officer acquired 236,360 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 30,000 shares at $19.09 ($572,835)
- 4 Planned sale Chief Financial Officer sold 30,000 shares at $15.69 ($470,622)
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 3,309 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 12,336 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 8,366 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 12,111 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 1,710 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 308 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,517 shares (to pay taxes)
Page 9 of 65 · 1,293 filings